Hosted on MSN28d
GE HealthCare upgraded at Jefferies on pullback, growthHe highlighted Flyrcado -- a positron emission tomography myocardial perfusion imaging (PET MPI) agent approved in September 2024 -- which GE HealthCare has projected as a $500M opportunity by 2028.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback